Botanical Drug Product Guidance Sets Foreign Marketing Data Requirements
This article was originally published in The Tan Sheet
Executive Summary
Companies interested in submitting an IND to conduct clinical trials on a botanical that has only been extensively available abroad must supply the agency with sales data as well as information on consumer exposure and adverse events.